Biomea Fusion, Inc. (BMEA)
NASDAQ: BMEA · Real-Time Price · USD
1.370
0.00 (0.00%)
At close: Mar 2, 2026, 4:00 PM EST
1.360
-0.010 (-0.73%)
Pre-market: Mar 3, 2026, 6:01 AM EST
Biomea Fusion Market Cap
Biomea Fusion has a market cap or net worth of $96.86 million as of March 3, 2026. Its market cap has decreased by -23.19% in one year.
Market Cap
96.86M
Enterprise Value
57.10M
1-Year Change
-23.19%
Ranking
Category
Stock Price
$1.37
Market Cap Chart
Since the IPO on April 16, 2021, Biomea Fusion's market cap has decreased from $489.05M to $96.86M, a decrease of -80.19%. That is a compound annual growth rate of -28.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 96.86M | 10.48% |
| Dec 31, 2025 | 87.67M | -37.65% |
| Dec 31, 2024 | 140.61M | -72.88% |
| Dec 29, 2023 | 518.45M | 109.21% |
| Dec 30, 2022 | 247.81M | 14.52% |
| Dec 31, 2021 | 216.38M | -55.75% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gossamer Bio | 99.20M |
| Anixa Biosciences | 98.80M |
| Vivani Medical | 97.42M |
| Seer, Inc. | 97.26M |
| aTyr Pharma | 97.01M |
| Kazia Therapeutics | 96.21M |
| PMV Pharmaceuticals | 95.78M |
| Dogwood Therapeutics | 95.59M |